Form 4: Pfizer Executive Rady A. Johnson Reports Acquisition of Phantom Stock Units
SEC Form 4 Filing
Executive Vice President Rady A. Johnson reports the acquisition of phantom stock units in Pfizer through the Supplemental Savings Plan.
Summary
- On July 31, 2024, Rady A. Johnson, an Executive Vice President at Pfizer Inc., acquired 6 phantom stock units through the Pfizer Supplemental Savings Plan (SSP).
- These units are settled in cash following separation from service and can be transferred into an alternative investment account at any time.
- Following the transaction, Johnson directly owns 9,119 phantom stock units.
- The price of the common stock related to the phantom stock units was $30.54.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing an executive's stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, providing transparency into the holdings of company executives. It reflects ongoing compensation and savings plans within Pfizer.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 07/31/2024 | Date of transaction: Rady A. Johnson acquired phantom stock units. |
| 08/02/2024 | Date of report: Form 4 filing date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.